Bio Haven: How Yale and New Haven are building a future together
New Haven’s biotech community has seen fits and starts, but today it is achieving critical mass. Upwards of 50 biotech and medical device companies employ more than 5,000 people in greater New Haven. Yale School of Medicine has been instrumental in the communty's growth.
Research in the news: How a mutated gene wreaks havoc on white matter
An inherited disease of myelin marked by slow, progressive neurological impairment is caused by mutations of a gene that controls lipid metabolism, a finding that may shed insight into mechanisms to control the course of multiple sclerosis (MS), a Yale team has found.
Taking a productive alliance further
In 2011 the School of Medicine formed a research alliance with the biopharmaceutical company Gilead Sciences, Inc. to accelerate the discovery and development of new drugs to treat cancer. Called “transformative” by then-Yale President Richard C. Levin, the collaboration included an initial commitment of up to $40 million to support research at the medical school over four years. Now, almost four years into the collaboration, the commitment has been renewed for an additional three years and an a
Gene mutation linked to Tourette syndrome
So much of what we do, we do on autopilot—whether tying our shoes or driving the same route to work. Functioning on autopilot frees our attention for other things, but it can also entrap us in inflexible and uncontrollable behaviors that assume lives of their own, said Christopher Pittenger, M.D., Ph.D., associate professor of psychiatry and in the Child Study Center and assistant professor of psychology, who studies how the brain’s cortical-basal ganglia circuits help to automate routine behavi
A new device deciphers the language of cells
As inventions go, Yale biomedical engineer Rong Fan’s entry into the innovation sweepstakes is not much to look at. Fan’s device, impressively named a single-cell, 45-plex protein secretion measurement platform, seems to be little more than a sandwich of two sheets of clear silicon rubber the thickness of window glass, each sheet a bit smaller than a credit card and bearing a smaller, darker rectangle divided into 14 vertical sections.
Mapmakers of the living human body
Imagine trying to develop a drug and being able to see how and where that drug acts inside the body of a living person. Just such a tool is provided by positron emission tomography (PET), an imaging technology that is aiding drug development and research on the mechanisms of disease at the School of Medicine’s state-of-the-art PET Center.
Yale alum builds a crucial bridge for psychiatry researchers
A $3 million gift to the Yale School of Medicine will establish a Psychiatry Research Scholars Program under the aegis of the Yale Child Study Center (CSC) and the Department of Psychiatry. The gift is from the family foundation of Herb Allison, M.B.A., a 1965 alumnus of Yale College.
Updates in Consultation-Liaison Psychiatry: 2019
Paula Zimbrean, MD, Associate Professor of Psychiatry; Walter Luchsinger, MD, Addiction Psychiatry Fellow; and Jordan Rosen, MD, Consultation-Liaison Psychiatry Fellow, are co-authors of a paper published in Psychosomatics that identifies the 10 most important manuscripts for clinical practice in consultation-liaison psychiatry from 2019.
Courses of Suicidal Ideation Among Military Veterans in Residential Treatment for Posttraumatic Stress Disorder
Noelle B. Smith, PhD, Assistant Clinical Professor of Psychiatry; Rani Hoff, PhD, Professor of Psychiatry; and Ilan Harpaz-Rotem, PhD, are co-authors of a study published in Depression & Anxiety that examines the prevalence and correlates of four courses of suicidal ideation among veterans receiving residential treatment for posttraumatic stress disorder.
Psilocybin-Assisted Therapy of Major Depressive Disorder Using Acceptance and Commitment Therapy as a Therapeutic Frame
Jordan Sloshower, MD, MSc, Research Fellow in Addiction Psychiatry, is the first author of a paper published in Journal of Contextual Behavioral Science that tracks the psychedelic assisted therapy of depression with the integration of Acceptance and Commitment Therapy.